Theliatinib is a potent and highly selective EGFR inhibitor, exhibiting a Ki of 0.05 nM for wild-type EGFR. It demonstrates anti-tumor activity in research models, with IC50 values of 3 nM and 22 nM against EGFR and the EGFR T790M/L858R mutant, respectively. This compound is applied in preclinical oncology research for investigating EGFR-driven cancers both in vitro and in vivo.
Molecular Weight:
442.51
Purity:
99.67% (May vary between batches)
CAS Number:
[1353644-70-8]
Formula:
C25H26N6O2
Target:
EGFR
Application Notes:
Solubility: DMSO:47 mg/mL (106.21 mM)
* VAT and and shipping costs not included. Errors and price changes excepted